• Myeloma UK
  • Clinical Service Excellence Programme
Myeloma Academy
Sign inRegister
Menu
  • Home
  • CPD & Learning
    • Myeloma Nurse Learning Programme
    • My CPD Portfolio
    • Challenging Cases
    • Close
  • Library
    • Guidelines
      • Complications
      • COVID-19 guidance
      • General haemato/oncology
      • Imaging & Analysis
      • Management & Treatment
      • Palliative Care
      • Presentation & Diagnosis
      • Related conditions
      • Close
    • Patient Support and Information
    • Medical animations
    • Close
  • Resources
    • Myeloma Drug Finder
    • Myeloma Trial Finder
    • Assessment tools
    • Myeloma Spotlight
    • Primary care education
    • Secondary care education
    • Myeloma health economic model
    • Close
  • News & Events
    • News
    • Event calendar
    • Meeting highlights
    • Close
  • CSEP
  • About Us
    • Contact Us
    • Close
Menu back  
 

Complications of myeloma and its treatments

Subclinical Peripheral Neuropathy in Patients With Multiple Myeloma Before Chemotherapy Is Correlated With Decreased Fingertip Innervation Density.
Kosturakis AK et al. J Clin Oncol. 2014 Aug 25. pii: JCO.2013.54.5418. [Epub ahead of print].

Hepatitis B virus reactivation in multiple myeloma patients receiving bortezomib-containing regimens followed by autologous stem cell transplantation.
Li J et al. Leuk Lymphoma. 2014 Aug 7:1-27. [Epub ahead of print].

Bortezomib-associated peripheral neuropathy requiring medical treatment is decreased by administering the medication by subcutaneous injection in Korean multiple myeloma patients.
Koh Y et al. Cancer Chemother Pharmacol. 2014 Aug 6. [Epub ahead of print].

Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure.
Breitkreutz I et al. Bone Marrow Transplant. 2014 Aug 4. doi: 10.1038/bmt.2014.165. [Epub ahead of print].

Peripheral neuropathy exacerbated by lenalidomide in a patient with multiple myeloma.
Kamimura T et al. Intern Med. 2014;53(15):1651-3. Epub 2014 Aug 1.

Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma.
Brioli A et al. Haematologica. 2014 Aug 1. pii: haematol.2014.110221. [Epub ahead of print].

Renal Insufficiency in Newly-diagnosed Multiple Myeloma: Analysis According to International Myeloma Working Group Consensus Statement.
Park S et al. Anticancer Res. 2014 Aug;34(8):4299-306.

  • Guidelines
  • Patient Support and Information
  • Medical animations
Bottom menu

Charity No. SC 026116
Myeloma UK
22 Logie Mill
Beaverbank Business Park
Edinburgh
EH7 4HG